GR1005424B - Method for quantitative determination of ck19 expression - Google Patents
Method for quantitative determination of ck19 expressionInfo
- Publication number
- GR1005424B GR1005424B GR20050100430A GR20050100430A GR1005424B GR 1005424 B GR1005424 B GR 1005424B GR 20050100430 A GR20050100430 A GR 20050100430A GR 20050100430 A GR20050100430 A GR 20050100430A GR 1005424 B GR1005424 B GR 1005424B
- Authority
- GR
- Greece
- Prior art keywords
- quantitative determination
- expression
- positive cells
- biological samples
- relates
- Prior art date
Links
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to a method for quantitative determination of CK-19 mRNA positive cells in biological samples. In particular the invention relates to a method for quantitative determination of CK-19 mRNA positive cells in biological samples of patients suffering from cancer before the initiation of any adjuvant treatment in order to provide information concerning the effectiveness of the adjuvant therapy.
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20050100430A GR1005424B (en) | 2005-08-17 | 2005-08-17 | Method for quantitative determination of ck19 expression |
KR1020087006461A KR20080036646A (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of ck19 expression |
CA002617693A CA2617693A1 (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of ck19 expression |
PCT/EP2006/008097 WO2007020081A1 (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of ck19 expression |
AU2006281569A AU2006281569A1 (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of CK19 expression |
US11/990,575 US20100015604A1 (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of ck19 expression |
EP06776902.6A EP1915461B1 (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of ck19 expression |
CN200680037658.3A CN101365800B (en) | 2005-08-17 | 2006-08-16 | Composition and method for determination of CK19 expression |
JP2008526444A JP2009504168A (en) | 2005-08-17 | 2006-08-16 | Composition and method for confirming CK19 expression |
US14/031,051 US9593374B2 (en) | 2005-08-17 | 2013-09-19 | Composition and method for determination of CK19 expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GR20050100430A GR1005424B (en) | 2005-08-17 | 2005-08-17 | Method for quantitative determination of ck19 expression |
Publications (1)
Publication Number | Publication Date |
---|---|
GR1005424B true GR1005424B (en) | 2007-02-01 |
Family
ID=38121845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR20050100430A GR1005424B (en) | 2005-08-17 | 2005-08-17 | Method for quantitative determination of ck19 expression |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101365800B (en) |
GR (1) | GR1005424B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102565404B (en) * | 2010-12-24 | 2014-04-16 | 牛刚 | Kit for detecting free colorectal cancer cell markers in blood |
CN102109525B (en) * | 2011-01-26 | 2013-10-16 | 牛刚 | Kit for detecting free breast cancer cell marker in blood |
CN103122387B (en) * | 2013-02-05 | 2015-02-04 | 苏州华益美生物科技有限公司 | Rapid circulating tumor cell (CTCs) fluorescence PCR (Polymerase Chain Reaction) hypersensitivity detection kit and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1656235B (en) * | 2002-05-21 | 2012-11-28 | 希森美康株式会社 | Nucleic acid amplification primers for detecting cytokeratins and examination method with the use of the primers |
ES2385248T3 (en) * | 2004-01-14 | 2012-07-20 | Novahep Ab | Human liver progenitor cells and methods of use thereof |
-
2005
- 2005-08-17 GR GR20050100430A patent/GR1005424B/en not_active IP Right Cessation
-
2006
- 2006-08-16 CN CN200680037658.3A patent/CN101365800B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101365800A (en) | 2009-02-11 |
CN101365800B (en) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL182423A0 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
WO2007016548A3 (en) | Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer | |
EA200971131A1 (en) | BIOMARKERS FOR PREDICTING SENSITIVITY OR NO SENSITIVITY TO ANTI-TNF AGENTS | |
BRPI0511139A (en) | compounds, pharmaceutical composition comprising them, method for inhibiting aurora kinase activity in a cell and method for treating an aurora kinase mediated disorder in a patient | |
WO2008104543A3 (en) | Method for predicting the occurrence of metastasis in breast cancer patients | |
WO2007081680A3 (en) | Microrna expression abnormalities in pancreatic endocrine and acinar tumors | |
MX2009012625A (en) | Methods of treating, diagnosing and detecting fgf21-associated disorders. | |
SG155163A1 (en) | Pharmacokinetically improved compounds | |
MX349787B (en) | Oral dosage forms including an antiplatelet agent and an acid inhibitor. | |
NO20076401L (en) | Diarylhydantoinforbindelser | |
WO2003106974A3 (en) | Diagnosis and treatment of chemoresistant tumors | |
ZA200803517B (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
ZA200803430B (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
TW200714283A (en) | Method and composition for treating peripheral vascular diseases | |
ZA200804509B (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
HK1145342A1 (en) | Prognosis prediction for melanoma cancer | |
EP1774043A4 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer | |
ZA200803516B (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
WO2008106175A3 (en) | Gene and protein expression profiles associated with the therapeutic efficacy of egfr-tk inhibitors | |
WO2009074968A3 (en) | Method for predicting the efficacy of cancer therapy | |
WO2007123722A3 (en) | Methods for prediction and prognosis of cancer, and monitoring cancer therapy | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
MX2013011431A (en) | Methods for predicting and improving the survival of gastric cancer patients. | |
MY147634A (en) | New crystalline forms | |
WO2008089135A3 (en) | Identification of biomarkers predictive of dasatinib effects in cancer cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PG | Patent granted | ||
ML | Lapse due to non-payment of fees |
Effective date: 20120302 |